Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641172-25-009565
Filing Date
2025-05-12
Accepted
2025-05-12 07:30:38
Documents
77
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q form10-q.htm   iXBRL 10-Q 1205724
2 EX-31.1 ex31-1.htm EX-31.1 18576
3 EX-31.2 ex31-2.htm EX-31.2 18540
4 EX-32.1 ex32-1.htm EX-32.1 7809
5 EX-32.2 ex32-2.htm EX-32.2 7835
  Complete submission text file 0001641172-25-009565.txt   6431035

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE wgrx-20250331.xsd EX-101.SCH 46538
7 XBRL CALCULATION FILE wgrx-20250331_cal.xml EX-101.CAL 69920
8 XBRL DEFINITION FILE wgrx-20250331_def.xml EX-101.DEF 195800
9 XBRL LABEL FILE wgrx-20250331_lab.xml EX-101.LAB 405450
10 XBRL PRESENTATION FILE wgrx-20250331_pre.xml EX-101.PRE 323280
79 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 967929
Mailing Address 3000 BAYPORT DRIVE SUITE 950 TAMPA FL 33607
Business Address 3000 BAYPORT DRIVE SUITE 950 TAMPA FL 33607 1-843-302-1785
Wellgistics Health, Inc. (Filer) CIK: 0002030763 (see all company filings)

EIN.: 933264234 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-42530 | Film No.: 25932584
SIC: 5122 Wholesale-Drugs, Proprietaries & Druggists' Sundries
(CF Office: 07 Trade & Services)